Article
CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical setting
2020-12-19
Abstract excerpt
<h4>ABSTRACT</h4> The well-recognized genome editing ability of the CRISPR-Cas system has triggered significant advances in CRISPR diagnostics. This has prompted an interest in developing new biosensing applications for nucleic acid detection. Recently, such applications have been engineered for detection of SARS-CoV-2. Increased demand for testing and consumables of RT-qPCR assays has led to the use of alternate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1dc61be5-82d3-57d9-82ca-fc25a4b22c10
- DOI
- 10.1101/2020.12.17.20228593
